US2011224714A1PendingUtilityA1
Methods and devices for the surgical creation of satiety and biofeedback pathways
Est. expiryMar 23, 2024(expired)· nominal 20-yr term from priority
Inventors:Michael Gertner
A61B 2017/0464A61B 2017/0496A61B 2017/0445A61B 17/00234A61B 17/29A61B 2017/00398A61B 2017/00827A61B 2017/00871A61F 5/0086A61B 17/0469A61B 2017/0458A61B 2017/0488A61B 17/0401A61B 2017/06052A61F 5/0076A61B 2017/0404A61B 2017/0454A61B 17/0487A61B 2017/0417A61B 2017/0456A61B 2017/0409
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are devices and systems which to sense parameters related to the mechanical forces imposed on devices implanted in the stomach. The parameters of the system are further translated into patient feedback systems to create satiety inducing pathways in the stomach.
Claims
exact text as granted — not AI-modified1 . A device to treat obesity comprising:
a restrictive balloon adapted to circumscribe the stomach and which defines a restrictive volume of the stomach; and an integral sensor located with the balloon wherein the sensor is responsive to changes in the restrictive volume of the stomach.
2 . The device of claim 1 , wherein a portion of the restrictive balloon is attached to the abdominal wall.
3 . The device of claim 2 , wherein the restrictive balloon is attached to the abdominal wall by an anchor.
4 . The device of claim 1 further comprising a wireless transmitter configured to transmit information from said integral sensor.
5 . The device of claim 1 further comprising a system efferent pathway with a first end and a second end;
wherein the first end of said system efferent pathway is attached to said device to treat obesity and the second end of said system efferent pathway is configured to be attached to a patient afferent pathway.
6 . The device of claim 5 wherein said patient afferent pathway is a visceral nervous pathway.
7 . The device of claim 5 wherein said patient afferent pathway is a vagal nerve pathway.
8 . The device of claim 5 wherein said patient afferent pathway is a layer of the stomach.
9 . The device of claim 5 wherein said patient afferent pathway is a cutaneous nervous pathway.
10 . A method of inducing satiety in a patient comprising:
implanting a restrictive balloon to circumscribe the stomach of a patient wherein the restrictive balloon defines a restricting volume and wherein the restrictive balloon further comprises an integral sensor to detect changes in the restricting volume; detecting changes in a restricted volume defined by the restrictive balloon; and transmitting the detected changes of the restricted volume to a device efferent pathway and thence to a patient afferent pathway for stimulation, wherein the stimulation induces satiety in the patient.
11 . The method of claim 10 , wherein a portion of the restrictive balloon is attached to the abdominal wall.
12 . The method of claim 11 , wherein the restrictive balloon is attached to the abdominal wall by an anchor.Join the waitlist — get patent alerts
Track US2011224714A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.